Connecting European Neuroscience

José Luis Lanciego Pérez

Ordinary member, Committee for Higher Education and Training (CHET) (July 2020 - July 2022)

Curriculum Vitae                                                  

Present position

Staff Scientist and Director, Laboratory of Functional Basal Ganglia Neuroanatomy Center for Applied Medical Research
University of Navarra, Pamplona, Spain

Professional and academic career

José L. Lanciego is a Staff Scientist at the Center for Applied Medical Research, and Associate Professor of Neurosciences at the University of Navarra Medical School, Pamplona, Spain. Originally trained as a Medical Doctor (University of Salamanca, June 1990), he received his PhD in Neurosciences with honors at the University of Salamanca in October 1994. Later on he joined the Department of Anatomy at the Amsterdam Vrije Universiteit, as a postdoctoral fellow under the supervision of Dr. Floris G. Wouterlood (1992 and 1996), with a main focus on neuroanatomical tracttracing techniques. In February 1997 he moved to the University of Navarra to be engaged in different studies dealing with the neurobiology of Parkinson’s disease. At present he is ahead of the Laboratory of Functional Basal Ganglia Neuroanatomy.

Education

1984-1990: Graduate in Medicine & Surgery, University of Salamanca
1990-1994: Doctorate in Medicine, Neurosciences Program, University of Salamanca 1996-1996: Postdoctoral Fellow, Dept. Neurosciences, Amsterdam Vrije Universiteit

Previous positions

1992-1997: Assistant Professor Human Histology, Univ. Salamanca Medical School
1996-1996: Postdoctoral Fellow, Department of Anatomy, Amsterdam Vrije Universiteit
1997-2000: Assistant Professor Neuroanatomy, Dept. Anatomy, University of Navarra
1997-2000: Junior Scientist, Center for Applied Medical Research, Univ. Navarra 
2000-present: Staff Scientist, Center for Applied Medical Research, Univ. Navarra
2002-present: Associate Professor Neuroanatomy, Dept. Anatomy, Univ. of Navarra

Honours and awards 

2020-2023: H2020 call topic SC1-BHC-01-2019 “AND-PD” (Co-PI)
2020-2022: Joint Program in Neurodegenerative Disorders “GBA-PaCTS” (Co-PI) 2014-2019: European Research Council Advanced Grant “REPROPARK” (Co-PI) 2014-2015: Network Centers Excellence Neurodegeneration (COEN-Pathfinder) (PI) 2012-2016: FP7 MCIAPP grants “BRAINVECTORS” (PI)
2009-2012: ERANET – Neurodegenerative Diseases “HETEROPARK” (PI)

Administrative & organisational experience

He is coeditor of the third edition of Neuroanatomical TractTracing Methods, Associate Editor of Frontiers in Neuroanatomy and Frontiers in Molecular Neuroscience as well as a member of the Editorial Board of Brain Structure and Function and Frontiers in Neuropharmacology. He is a member of the Society for Neuroscience (SfN; US), the International Basal Ganglia Society (IBAGS; US) and the Spanish Society for Neurosciences (SENC; Spain). Since January 2017 he is serving as a Board Member of the IBAGS Council. In January 2020 he has been elected as a member of the International Brain Research Organization PanEuropean Committee (IBROPERC), and further appointed as IBROPERC representative at the Committee for Higher Education and Training from the Federation of European Neuroscience Societies (FENSCHET). He has published a total of 118 papers in international scientific journals. H index is 37 based on the ISI Web of Science (July, 2020), contributed to 10 chapters to scientific books, and coedited 3 books. Currently available funding includes research grants from European agencies (H2020; JPND; ERC Advanced, CoENPathfinder and EranetNeuron), from the Spanish Ministry of Science as well as from charities (Fundació La Marató TV3). He has been recognized as “Group of Excellence” in the field of Neurodegenerative Diseases by the Spanish Ministry of Health since December 2006, therefore joining the socalled “Network Center for Biomedical Research in Neurodegenerative Disorders” as a founding member.

International and national responsibilities

Member, Spanish Society for Neurosciences (since 1994)
Member, Society for Neuroscience (since 1996)
Member, International Basal Ganglia Society (since 2004)
Editorial Board Member, Brain Structure and Function (since July 2010)
Review Editor, Frontiers in Neuropharmacology (since 2016)
Member of the International Basal Ganglia Society Council Board (IBAGS; since 2017)
Associate Editor, Frontiers in Neuroanatomy (since August 2010)
Member of the International Brain Research Organization Pan-European Council Board (IBRO-PERC; since January 2020)
IBRO-PERC representative at the Federation of European Neuroscience Societies
Associate Editor, Frontiers in Molecular Neuroscience (since May 2020)
Council Board (FENS; Committee on Education and Training; since May 2020)

Research interests

His recent research interests include a number of projects dealing with the pathophysiology of Parkinson’s and Alzheimer’s diseases using nonhuman primate models. Recently his work has focused on the screening of a number of Gproteincoupled receptor heteromeric complexes across the basal ganglia in macaques, as well as a number of gene and cell therapies approaches for Parkinson’s disease.

Selected publications

Martínez-Pinilla et al. (2020) Expression of cannabinoid CB1R-GPR55 heteromers in neuronal subtyes of the Macaca fascicularis striatum. Ann NY Acad Sci, in press (doi: 10.1111/nyas.14413)

Lanciego JL, Wouterlood FG (2020) Neuroanatomical tract-tracing techniques that did go viral. Brain Struct Funct 225(4):1193-1224

Martínez-Pinilla et al (2019) Targeting CB1 and GPR55 endocannabinoid receptos as a potential neuroprotective approach for Parkinson’s disease. Mol Neurobiol 56(8(:5900-5910

Blandini F, et al. (2019) Glucocerebrosidase mutations and synucleinopathies: Toward a model of precision medicine. Mov Disord 34(1):9-21

Franco R, et al. (2018) Glucocerebrosidase mutations and synucleinopathies. Potential role of sterylglucosides and relevance of studying both GBA1 and GBA2 genes. Front Neuroanat 12:52

Guridi J, et al. (2018) History and future chanllenges of the subthalamic nucleus as surgical target. Mov Disord 33(10):1540-1550

Pignataro D, et al. (2018) Gene therapy approaches in the non-human primate model of Parkinson’s disease. J Neural Transm, 125(3):575-589

Dopeso-Reyes IG, et al. (2018) Glucocerebrosidase expression patterns in the non-human primate brain. Brain Struct Funct 223(1):343-355

Rodríguez-Pérez AI, et al. (2018) Angiotensin type 1 receptor antagonists protect against alpha-synuclein-induced neuroinflammation and dopaminergic cell death. Neurotherapeutics 15(4):1063-1081

Morabito G, et al. (2017) AAV-PHP.B-mediated global-scale expression in the mouse nervous system enables GBA1 gene therapy for wide protection from synucleinopathy. Mol Ther 25(12):2727-2742

José Luis Lanciego Pérez

Associate Professor of Neurosciences
Staff Scientist and Director, Laboratory of Functional Basal Ganglia Neuroanatomy Center for Applied Medical Research
University of Navarra, Pamplona, Spain
Researcher ID: G-7759-2015
ORCID ID: 0000-0003-2301-5419

loading